Mieloma multiplo: approcci innovativi nelle fasi precoci della malattia

Multiple myeloma treatment is being redefined with new, advanced options, raising questions about efficacy, safety, and timing of use. Which patients can benefit? How does the complex process that transforms immune system cells into a weapon against cancer work? And what impact can this innovative approach have on quality of life and the course of the disease? We discussed this with Francesca Gay, Associate Professor of Hematology at the University of Turin.